{
    "clinical_study": {
        "@rank": "13112", 
        "acronym": "MYCOS", 
        "arm_group": [
            {
                "arm_group_label": "1) parenteral micafungin users"
            }, 
            {
                "arm_group_label": "2) other parenteral antifungal users"
            }
        ], 
        "brief_summary": {
            "textblock": "This multicenter observational cohort study proposes to establish the risks of short and\n      long-term outcomes in users of parenteral micafungin and in users of other parenteral\n      antifungal agents from 2005 through 2012 with follow-up until 2017."
        }, 
        "brief_title": "Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents", 
        "completion_date": {
            "#text": "November 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Systemic Fungal Infections", 
        "condition_browse": {
            "mesh_term": "Mycoses"
        }, 
        "detailed_description": {
            "textblock": "All eligible patients treated with a parenteral antifungal agent at any time during the\n      years 2005-2012 in each of the participating hospitals, will be included in the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  hospitalized and treated with parenteral antifungal medication\n\n          -  first time treatment of the patient with parenteral antifungal in the medical center\n             was anytime from 2005 through 2012\n\n        Exclusion Criteria:\n\n          -  prior diagnosis of hepatocellular carcinoma\n\n          -  had received parenteral antifungal therapy during the 6 months prior to index\n             hospitalization"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients treated with parenteral antifungals in tertiary referral centers across the\n        United States."
            }
        }, 
        "enrollment": {
            "#text": "35000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686607", 
            "org_study_id": "9463-CL-1401"
        }, 
        "intervention": [
            {
                "arm_group_label": "1) parenteral micafungin users", 
                "intervention_name": "Parenteral micafungin application", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "2) other parenteral antifungal users", 
                "intervention_name": "Other parenteral antifungal drugs", 
                "intervention_type": "Drug", 
                "other_name": [
                    "'other antifungals' include the following drugs:", 
                    "caspofungin, anidulafungin, fluconazole, itraconazole, voriconazole, amphotericin B (various formulations)"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amphotericin B", 
                "Antifungal Agents", 
                "Clotrimazole", 
                "Miconazole", 
                "Anidulafungin", 
                "Micafungin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Antifungals (parenteral)", 
            "Micafungin", 
            "Hepatocellular carcinoma", 
            "Hepatic toxicity", 
            "Renal toxicity"
        ], 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21218"
                    }, 
                    "name": "Johns Hopkins University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham and Women's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109"
                    }, 
                    "name": "University of Michigan Hospital and Health System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "Duke University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadephia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104-6205"
                    }, 
                    "name": "University of Pennsylvania Office of Research Services"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "15213-2582"
                    }, 
                    "name": "University of Pittsburgh Medical Center"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents", 
        "overall_official": {
            "affiliation": "WHISCON, LLC", 
            "last_name": "Lead Investigator", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "European Union: European Medicines Agency", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2020", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Data will be used of patients treated during the years 2005-2012 with a parenteral antifungal agent in the participating centers.", 
                "measure": "Treatment-emergent hepatic injury or dysfunction", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 30 days after termination of the index treatment"
            }, 
            {
                "description": "Data will be used of patients treated during the years 2005-2012 with a parenteral antifungal agent in the participating centers.", 
                "measure": "Treatment-emergent renal failure or dysfunction", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 30 days after termination of the index treatment"
            }, 
            {
                "description": "Data will be used of patients treated during the years 2005-2012 with a parenteral antifungal agent in the participating centers.", 
                "measure": "Rehospitalization for the parenteral treatment of fungal infections", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 30 days after termination of the index treatment"
            }, 
            {
                "description": "On a long-term basis up to 13 years from 2005-2017.", 
                "measure": "Death from hepatocellular carcinoma (HCC)", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 13 years after treatment"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686607"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Astellas Pharma Inc", 
        "sponsors": {
            "collaborator": {
                "agency": "World Health Information Science Consultants, LLC", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Astellas Pharma Europe B.V.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}